Lifevantage (NASDAQ:LFVN) Stock Price Passes Above 200 Day Moving Average – What’s Next?

Lifevantage Corporation (NASDAQ:LFVN) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $5.76 and traded as high as $6.69. Lifevantage shares last traded at $6.57, with a volume of 44,291 shares trading hands.

Analyst Ratings Changes

Several research firms have commented on LFVN. Weiss Ratings raised shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Lake Street Capital lowered shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price objective on the stock. in a research note on Thursday, May 7th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, Lifevantage presently has a consensus rating of “Hold” and a consensus target price of $5.00.

Lifevantage Trading Up 1.2%

The company’s 50-day moving average price is $6.70 and its two-hundred day moving average price is $5.76. The company has a market cap of $82.91 million, a P/E ratio of 14.60 and a beta of 0.72.

Institutional Investors Weigh In On Lifevantage

A number of institutional investors and hedge funds have recently modified their holdings of LFVN. Goldman Sachs Group Inc. grew its holdings in shares of Lifevantage by 305.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 200,222 shares of the company’s stock worth $1,233,000 after acquiring an additional 150,785 shares during the last quarter. Geode Capital Management LLC increased its stake in Lifevantage by 106.1% in the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after purchasing an additional 126,274 shares in the last quarter. Renaissance Technologies LLC raised its holdings in Lifevantage by 8.3% during the 4th quarter. Renaissance Technologies LLC now owns 922,918 shares of the company’s stock worth $5,685,000 after buying an additional 70,900 shares during the period. Capital Management Corp VA lifted its stake in Lifevantage by 3.4% during the fourth quarter. Capital Management Corp VA now owns 2,134,574 shares of the company’s stock valued at $13,149,000 after buying an additional 70,398 shares in the last quarter. Finally, Indivisible Partners purchased a new stake in Lifevantage during the fourth quarter valued at about $399,000. Institutional investors and hedge funds own 35.32% of the company’s stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.